News

LineaBio submits Drug Master File for Linea 1 GMP iPSC line to U.S. Food and Drug Administration

November 20, 2024 (Toronto, Ontario) – LineaBio announced it has submitted a Type II DMF to the FDA for its flagship iPSC line, Linea 1. […]

Read More… from LineaBio submits Drug Master File for Linea 1 GMP iPSC line to U.S. Food and Drug Administration

LineaBio launches off-the-shelf GMP iPSC lines to accelerate iPSC-based cell therapies

July 30, 2024 – LineaBio, a cell line company, today announced the launch of its off-the-shelf induced pluripotent stem cell (iPSC) lines catalogue. […]

Read More… from LineaBio launches off-the-shelf GMP iPSC lines to accelerate iPSC-based cell therapies